
Slenderiix Clinical Trial Results
Abstract
A Randomized, Blind, Placebo-Controlled Cross-Over Study: Exploring the relationship of an exclusive homeopathic weight loss tincture combined with therapeutic nutrition in relation to reversal of visceral adipose fat tissue stores and serum inflammatory markers, which indicate risk factors for leading causes of death, including congestive heart disease and hormone-related cancers.
The placebo-controlled study evaluates subjects’ hormonal, physiological, and physical responses to: a patented blend of homeopathic ingredients, (herein after referred to as “Slenderiix”), in conjunction with the methyl-form of B vitamins compounded with adaptogenic herbs, (herein after referred to as Xceler8, and when employed compatibly, are known as The Slenderiiz Weight Loss Program); therapeutic nutrition, optimal hydration from purified water; appropriate nutritional supplementation for optimal metabolism; a detoxifying restorative blend of zeolite minerals and nutrient dense green super-foods, (herein after referred to as “Restoriix”); and a whole food antioxidant-based energy and focus formula for enhanced dopamine utilization and neurotransmitter communication, (herein after referred to as Rejuveniix).
Visceral adipose fat tissue measures and serum inflammatory markers that indicate health risks were improved. Serum measures related to cholesterol and triglycerides were significantly improved. The cardiac inflammation metric HS-CRP was significantly reduced and blood sugar levels related to glucose, HbA1C and insulin were also improved.
Introduction
Slenderiix Homeopathic Tincture
Homeopathic preparations are recognized as drugs under the Federal Food, Drug, and Cosmetic Act (“FD&C Act”), 21 U.S.C. § 201 et seq. Section 201(g)(1) of the FD&C Act, 21 U.S.C. § 321(g)(1), which defines the term “drug” as “articles recognized in the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States, or official National Formulary, (i) or any supplement to any of them . . . .” (40)
Slenderiix employs a modernized approach to homeopathy, blending individual time-proven remedies into one cohesive formula to effectively address all imbalances which contribute to today’s epidemic of abnormal weight gain.
Contributing factors include hormonal responses to excessive stress—whether dietary, emotional or environmental; capacity for cellular detoxification, neurotransmitter communication, stable hunger patterns and freedom from addictive behaviors. All of these contribute to systemic flushing of abnormal fat stores, when balance in achieved. Slenderiix was successfully tested in over 10,000 patients prior to ARIIX obtaining exclusivity and beginning in-house beta testing and clinical observation.
The Materia Medica catalogs all methodology within the discipline of homeopathy and references the functions of each remedy as excerpted below:
Ammonium Bromatum: Indicated in chronic laryngeal and pharyngeal catarrh, neuralgic headaches, and obesity.
Graphites: An anti-psoric carbon, most active in stout individuals with fairer complexions, with tendencies toward skin affections and constipation, excess fat storage with tendency to obesity, chronic low body temperature, with delayed menstrual history, who become cold easily, may suffer anæmia with redness of face, tendency toward inflammation of the pylorus or duodenal illness.
Sulfuricum Acidum: This remedy supports those with chronic acidosis, digestive tract abnormalities, and may be evidenced by a craving for stimulants. Tremor and weakness, hurried temperament, hot flashes followed by perspiration with trembling, diminished rate of healing after medical procedures, gastralgia and hypochlorrhydria.
i. Since the passage of the FD&C Act, the United States Pharmacopoeia and the National Formulary have merged.
ii. As noted, with the merger of the United States Pharmacopoeia and the National Formulary there are only two “official” compendia.
Xceler8: Metabolism and Energy Support
Xceler8 is a patented blend of methylcobalamin (natural B12), biotin, and a synergistic blend of a specific classification of herbs known as adaptogens; so named due to their proven ability to improve resilience to stress, increase adaptive responses and to reduce the perception of stress. (42)
Appropriate Supplementation: Vitamins and Minerals
ARIIX’s Vitamin and Mineral, known as “Optimals” contain a signature whole food dried vegetable juice blend that is certified to be grown from GMO-free seeds and without pesticides. This blend includes broccoli, carrot, tomato, beet, spinach, cucumber, Brussels sprout, cabbage, celery, kale, asparagus, green bell pepper, cauliflower, parsley, and wheat grass. The vegetable blend adds important enzymes, peptides, and phytonutrients that support the body’s ability to absorb and utilize vitamins and minerals, and to help offset the diets of those who have low daily consumption of vegetables. Rice bran contributes naturally whole complex antioxidants, magnesium, calcium, Vitamin A carotenoids, and nine B vitamins, along with several essential amino acids and phospholipids, which are necessary for maintaining healthy cell membranes.
Due to these findings, high-quality multi-vitamin supplementation is recommended as a low-cost preventative intervention in combination with the healthiest possible food choices. This is the best low cost adjunctive for optimal health and reducing the risk of common age-related diseases associated with obesity, and ultimately death by secondary diseases of CHD and cancer.
Appropriate Supplementation: Omega 3 Fatty Acids
It is now generally maintained that inflammation is the root cause of the chronic degenerative conditions. Systemic inflammation is indicated by abnormal fat storage, swelling, chronic joint and bone pain, allergies, asthma, and headaches in the early stages; but also heart disease, cancer and neurological diseases, as the above mentioned earlier symptoms continue unchecked.
Appropriate Supplementation: Restoriix
ARIIX Restoriix is a blend of zeolite, chia seeds and nutrient-dense organic spirulina, chlorella and chlorophyll. Zeolites are highly alkaline minerals that contain large structural vacancies and carry a negative ionic charge, giving them superior binding adhesion to positively charged pathogenic toxins. The zeolite blend sourced for Restoriix is ultra-purified and certified free of lead and other contaminants, common to earth-sourced minerals. The highest grade nano-sized particles provide for increased surface area adhesion of free radicals and environmental pathogens, as well as a smooth, palatable texture. Zeolite’s magnet-like effect attracts impurities and binds them within its honeycomb-like molecular structure, preventing the resorption of toxins as they are excreted from the body through the natural process of digestion.
Appropriate Supplementation: Rejuveniix
Rejuveniix is an energy-boosting blend of low-temperature dehydrated fruit and berry extracts, chosen for their wide variety of polyphenols and bioflavanoids. Effectively combined with green coffee bean extract, kava kava root extract and the amino acid l-theanine, this formula has been observed to provide increased mental clarity, stamina and focus. A unique extraction process leaves exceptionally high levels of the beneficial antioxidant levels intact, while producing a product that contains no fructose.
The focus and energy portion of the Rejuveniix formula comes from a balance of the amino acid l-theanine, kava kava root extract and green coffee bean extract. ARIIX only sources the highest quality kava kava root from the Republic of Vanuatu due to superior potency and highest lactone content. This lends properties that support healthy blood pressure and the ability to relax the mind and muscles without sedative effects and loss of mental clarity.
L-theanine is sourced from green tea leaves and directly stimulates the production of alpha brain waves, allowing mental alertness (29) and also increases dopamine, “the satisfaction neurotransmitter”, allowing individuals to experience a greater sense of pleasure and fulfillment. (30)
Green Coffee Bean Extract (GBCE) is a rich source of chlorogenic acid, which has been shown to have significant effects on both body mass and reducing body fat when used long term in both overweight and obese subjects. (31) Green coffee bean extract has also been shown to suppress hepatic production of triglycerides, reducing fat accumulation. (32) GCBE also works synergistically with kava kava and l-theanine, enhancing effectiveness.
Methodology
Twenty three individuals were chosen for the initial study; three men and 20 females ranging in age from 21 to 75. Individuals were selected on the basis of commitment to completing the 12 week course. Subjects were selected due in part to a desire for weight loss, with at least 12, to as much as 120 pounds to lose.
Subjects were required to maintain compliance for 12 weeks with a specific nutritionally dense diet, appropriate supplementation, adequate fluid intake, simple exercise, and detoxification and stress management techniques. Examples included keeping a food journal, exercise, personal contact, accountability and counsel.
Subjects were given a 1,250 calorie, low-glycemic, low starch, functional food meal plan that included a minimum amount of healthy fats from coconut oil, avocados and raw sprouted nuts or their cold pressed oils. Because the FDA’s defined daily minimum caloric threshold for a “Low-fat Diet” is set at 30% or less of daily calories coming from fat, a minimum of 300 calories of the 1250 allowable calories were specified to be selected from healthy fat.
Participants simultaneously excluded all inflammation-causing omega 6 vegetable oils such as canola, soybean, grape seed, olive oil and any other oil which can contribute to inflammatory cytokine production within the body, and/or compete with omega 3 for conversion/uptake. Inappropriate balance of omega 3 to 6 oils blocks the pathway to healing metabolism, alters cell signaling and optimal neurotransmitter and hormone rebalance, and blunts potential of therapeutic efficacy intended by including Omega-Q.
Subjects were instructed to choose at least twice as many non-starchy fresh vegetables as protein portions per meal to provide plenty of fiber rich carbohydrates which are also dense in anti-inflammatory nutrients.
All groups, except the placebo group, were using the Slenderiix and Xceler8 before each meal throughout the 12 week trial. With all groups the following constants remained for the duration of the study period: food selection guidelines and daily calorie max intake, appropriate hydration to include a minimum of 5 (total based on individual weight) refills of the Puritii water bottle daily, with individual increased adjustments for weight-appropriate amounts of water, and a minimum amount of exercise of 20 minutes of walking, 5 times per week.
Subjects were observed and feedback was given, comparing results of individuals with and without the use of Slenderiix and Xceler8; as well as with Slenderiix, Xceler8, foundational Nutritional Supplementation; and a final group who employed all of the above items, plus including Rejuveniix. Subjects committed to weekly counseling and instruction with Dr. Hurt. Before and after, and at four-week intervals, subjects’ measurements, weight and photos were documented. Before and after, a comprehensive blood work panel was drawn and evaluated. This panel consisted of serum inflammatory indicators of the presence of fat storage metabolism, known markers that are precursors to diabetes, heart disease and chronic inflammatory conditions such as cancer. Weight, measurements, and fat store location were documented, reviewed, and compared.
Subjects receiving Nutrifii Nutritional supplements of Vitamins, Minerals, Restoriix, and/or Rejuveniix were to take them as directed on the product label. Omega-Q was given, as noted above, in a dose that is double the label guidelines. All subjects were required to take 15 drops of Slenderiix, under the tongue 10 minutes before each meal. Additionally subjects took 15 drops of Xceler8 under the tongue with breakfast and lunch. Subjects not receiving either Slenderiix or Xceler8 were given a placebo.
Beyond the diet, subjects were required to drink a minimum of 50% of their respective body weight of water, in ounces each day. Regardless of weight, 100 ounces was the minimum amount of water for each subject each day with no maximum limit.
Results
Of the initial 23 subjects, 19 completed the program. Results of following a regimen of calorie limited nutrient dense diet, appropriate supplementation, hydration, and detoxification with moderate exercise, coupled with use of specific products yielded statistically significant results compared to reducing calories alone. The table below provides a summary of the average rate of weight loss per day over time.
Since subjects were classified into four equal groups (n=5), an ANOVA was conducted to determine significance across groups. Even given the small sample size created by the factorial design, results show that significant differences existed between groups (F ratio 14.2 p<.01).
Furthermore, all groups were found to be significantly different from no diet whatsoever (p<.0001).
As the table depicts, over time the rate of weight loss tapers off with each successive month of weight loss. 89.5% of subjects exceeded their personal targeted weight loss goal, projected at the onset of the trial.
Of the two subjects who did not reach their 12 week projected weight goal, one subject was only 1.6 pounds short of the 25 pound projected possible weight loss for females, and the other subject was within 3.8 pounds of study projections. It should be noted that the latter subject had exceeded her personal goal of losing 20 pounds. Once personal expectations were fulfilled at completion of the 7th week of the trial, she experienced no additional weight loss in the remaining 5 weeks of the program. This observation supports psychological theory that personal expectations play a significant role in weight loss outcomes in regard to the possibility of subconscious behaviors sabotaging what ultimately may be possible. In total, the rate of weight reduction per day experienced by all Slenderiix using groups consistently exceeded the rate of weight loss compared to calorie restricted diet alone.
Biomarkers which are key indicators of metabolic syndrome, diabetes, cardiac disease and cancer risk factors were measured through serum testing both before and after the 12 week trial. Unfortunately, circumstances limited collection of lab values from every subject, which prevented reporting on every lab value examined. The individuals were to get a selected list of disease markers drawn, which are known in preventative medicine as indicators of fat storage, obesity, diabetes and precursors to heart disease and some cancers. Because these labs were to be ordered and collected by each subject’s physician, several physicians declined follow-up labs after the 12 week trial was over. In many cases, this was due to the obvious considerable weight loss and physicians’ no longer deemed the labs as medically necessary, which precluded insurance covering the cost of the follow up labs. Due to logistical complications such as this, almost half of subjects were not able to provide follow up lab values for certain tests.
A collection of serum markers that accompany the onset of abnormal fat storage, specifically in the disproportionate deposition of visceral adipose tissue (VAT), have been associated with the pathology of insulin resistance. These blood levels have interrelated relationships in obesity-related disease pathology. Integrative physicians now understand that although individually these lab indicators may enter the health assessment picture at different times due to biochemical individuality, certainly metabolic syndrome is continuing to worsen along with the increased inability to shed excess weight easily. Over time the appearance of more and more of these particular serum markers continue to underscore the depth of the disease pathology that is pushing the patient closer to cardio-metabolic disorders and hormone related cancers, our number one and two causes of death.
These serum levels are as follows: elevated triglycerides, total cholesterol serum insulin; decreased HDL cholesterol and glucose tolerance.
Over time, insulin resistance progressively becomes more severe and continues to affect function of more organs. When serum glucose levels remain elevated, there is increased likelihood of protein glycosylation and overproduction of free-radical producing oxidative stress, which have proven association with initial central obesity, and eventual atherosclerosis, type II diabetes, heart disease and cancers. The body’s typical reaction of producing more and more insulin leads to insulin resistance in various locations throughout the body as disease progresses. In the skin, insulin resistance can be revealed as acne, while insulin resistance in the brain over time becomes Alzheimer’s—recently given the name Diabetes Type III.
The Serum Measures Chart above reflects that all serum risk factors tested for cardio-metabolic disorders were significantly reduced.
Physical measurements of subjects’ chest, waist and hips, before and after, reflected that all Slenderiiz-using subjects lost a significant amount of fat in the waist measurement, indicating decrease in visceral adipose tissue stores, as well as associated mortality risks of central obesity.
Within the first 4 weeks of the trial, several of the placebo subjects, though weight loss was reflected on the scale and visibly in the face and extremities, did not lose any inches from their waist measurement. One placebo subject, whose total loss goal at the onset of the trial was only 12 lbs, reported initial concern over the loss of significant inches in the chest and extremities, without any loss of weight in the midsection measures. After the crossover to the active Slenderiix, subject continued to lose the last few pounds to reach her goal, but also noticed a remarkable redistribution of normal body fat to the more desirable female areas, as her weight stabilized to a new set point during the remaining few weeks on the active product.
All Slenderiix-using groups reflected significant inches lost in the waist measurement, as compared to the chest and hips throughout every stage of the trial. This confirms the ability of the Slenderiiz program to target release of fat stores in the area of dangerous visceral adipose fat. Although the full extent of the mechanisms that allow this to be possible are yet unknown, serum tests reflect a regain in glycemic control, thus reversing the progression of insulin resistance—first heralded by the visible increase in visceral adipose tissue at the waist measurement—and the pathological risks that would have followed in time.
Cardio-metabolic Risk Assessors that accompany excess Visceral Adipose Tissue
Typically, as insulin secretion increases, blood triglycerides and glucose levels continue to rise, while HDL levels slowly decrease and VAT begins to accumulate. Since insulin is released in response to too much glucose in the blood, and HbA1c represents the amount of hemoglobin molecules that have had glucose molecules attached to them in the blood stream, these two serum markers typically rise and fall together. Serum levels of insulin within study subjects decreased an average of 27.7%, and correlating HbA1c also decreased 4.4%.
Even though all cholesterol levels were monitored and improved upon, the cholesterol values that are specific to indicate systemic inflammation are now accepted to be most pertinent to reversing the interrelated risks of heart disease and obesity.
The pathology of arterial plaque formation in heart disease has been proven to be caused by several factors effecting inflammatory response to the small vascular injuries that occur from a cascade of reactive events. Over-production of insulin from sugar and starch consumption, increased platelet adhesion due to omega 3 fat deficiency with omega 6/9 excess and antioxidant deficiency, emotional stress, all theses sources of oxidative stress contribute to inflammatory pathology. If inflammation is eliminated, arteries are clear, regardless of total cholesterol levels. Across all cholesterol markers, subjects responded with significant improvements in all areas.
The fraction of cholesterol that indicates potential endothelial inflammatory damage is called Very Low Density Lipoproteins (VLDL). Due to excessive free radical production, when cholesterol is oxidized into VLDL, it indicates an insufficient amount of antioxidants available within the body. VLDL can be significantly reduced by supplementing adequate vitamins, minerals and antioxidants, by modulating increases, beyond standard dosing, appropriate to the level of stress of the individual. This inflammatory marker, VLDL was significantly reduced.
The National Institutes of Health funded the VITAL study to asses the effect of vitamin D and omega 3 supplementation on the prevention of cancer and heart disease. (23) This was a large-scale randomized trial which also made correlations to fasting insulin, glucose, altered cholesterol ratios and the prevalence of metabolic syndrome. Findings proved that the lower the serum vitamin D, the more prevalent these inflammatory makers for insulin resistance progressing to metabolic syndrome. Increasing serum 25(OHD) is associated with a responsive lowering of VAT, triglycerides, triglyceride/HDL-cholesterol ratio. Within this trial period, subjects serum vitamin D increased an overage of 15.7% overall, raising serum levels of 9 out of 10 subjects to reflect an optimal range of 40-69 ng/ml, and the remaining subject at 39.10 ng/ml. Due to the seasonality of the trial beginning fall and ending mid-winter, these results are impressive, considering vitamin D levels typically plummet in winter months and fat stores simultaneously increase.
Higher levels of Highly Sensitive C-Reactive protein are linked to higher occurrences of sudden cardiac death, strokes, peripheral artery disease and myocardial infarction. HS-CRP is an inflammatory particle produced by the liver in response to stressors. Trial subjects averaged a 24% reduction in HS-CRP.
The ratio of TG to HDL is a reliable indicator of the extent of insulin resistance on cholesterol metabolism. (27) Subjects within the Slenderiix Clinical Trial produced a 41% reduction in Triglyceride to HDL ratios, significantly reducing serum-defined insulin resistance and cardio-metabolic risk.Paragraph
Conclusions
Results of the study found that all groups statistically lost more weight, than those on no weight loss regimen whatsoever. However, subjects using Slenderiiz lost just over twice as much (103.4%) weight per day (.51 lbs p/day) compared to subjects on either a 1250 calorie diet alone (.24 lbs p/day) as well as the Placebo Group (.23 lbs p/day). Subjects taking Rejuveniix in conjunction with Slenderiiz had a significantly higher (+3%) rate of weight loss.
Triglyceride levels of all subjects taking ARIIX products significantly improved. The average subject experienced a statistically significant decrease of triglyceride levels of (p<.0005). According to Anti-aging medicine specialists, the single most important factor to increase life expectancy is the ability to increase HDL cholesterol as high above 40 ng/dL as possible. Within the 12 week period the average increase in HDL cholesterol of 15% brought 90% of subjects within optimal range in all ARIIX groups. This reflects significant (p<.0005) reduction in risk of all causes of disease-related death.
Approximately 90% of subjects achieved their weight loss objective during the study compared to none of the control group subjects. This finding suggests that the faster rate of weight loss, with less physical discomfort, the higher rate of compliance to maintain a weight loss program.
Finally, the physical, psychological and emotional changes in the subjects were observed. Subjects losing weight often comment on increased energy, confidence and enthusiasm to continue their new habits as a continued lifestyle. The psychological impact of being empowered with the knowledge and ability for individuals to create a metabolic shift in a completely new direction in such a short period of time was transformational for all test subjects taking ARIIX products, rather than calorie reduction alone.
References
1. Ames, B (2006)Proc. Natl. Acad. Sciences, U.S.A., 103:17589-94.
*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. It is advised that you consult a physician before starting any weight loss or exercise program. No results are guaranteed by any person. Results shown are not typical and will vary from person to person.
Slenderiiz® is the only healthy and natural weight management system of its kind, showing improved results over diet and exercise alone. To help expedite weight loss while maintaining proper levels of nutrition, our scientifically advanced Slenderiiz products assist in controlling appetite, aiding digestion and increasing metabolism to help maximize your efforts. Our Slenderiiz Program is a simple and effective tool that promotes fat reduction, increases weight loss and decreases the odds of problematic rebound weight gain.
Never give up on you!
“Self love is important. Make a difference in your life, and you can make a difference for others.”